Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent or Metastatic, Platinum-refractory Cervical Cancer”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Large-scale testing (Phase 3)Study completedNCT05802290
What this trial is testing

NIVolumab in Subjects With Recurrent or Metastatic Platinum-refrACTORy SCCHN

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Gruppo Oncologico del Nord-Ovest 124
Early research (Phase 1)Study completedNCT03508570
What this trial is testing

Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal Carcinomatosis

Who this might be right for
Malignant Peritoneal NeoplasmMalignant Retroperitoneal NeoplasmMetastatic Cervical Carcinoma+31 more
M.D. Anderson Cancer Center 26
Large-scale testing (Phase 3)Looking for participantsNCT06589804
What this trial is testing

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

Who this might be right for
Metastatic Head and Neck Squamous Cell CarcinomaMetastatic Hypopharyngeal Squamous Cell CarcinomaMetastatic Laryngeal Squamous Cell Carcinoma+18 more
National Cancer Institute (NCI) 158
Large-scale testing (Phase 3)Study completedNCT01166542
What this trial is testing

Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers

Who this might be right for
Carcinoma, Squamous Cell of the Head and Neck
Oncolytics Biotech 167
Testing effectiveness (Phase 2)UnknownNCT01377298
What this trial is testing

Pazopanib in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
National Taiwan University Hospital 45
Testing effectiveness (Phase 2)Ended earlyNCT00737360
What this trial is testing

Phase II Study of TAS-106 to Treat Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Taiho Pharmaceutical Co., Ltd. 27
Testing effectiveness (Phase 2)Study completedNCT00753038
What this trial is testing

Phase 2 Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Head and Neck Carcinoma

Who this might be right for
Carcinoma, Squamous Cell of the Head and Neck
Oncolytics Biotech 14
Testing effectiveness (Phase 2)WithdrawnNCT01427205
What this trial is testing

Phase II Study of Cetuximab With or Without OSI-906 in Head and Neck Squamous Cell Carcinoma (HNSCC)

Who this might be right for
Head and Neck Cancer
M.D. Anderson Cancer Center
Large-scale testing (Phase 3)Study completedNCT02105636
What this trial is testing

Trial of Nivolumab vs Therapy of Investigator's Choice in Recurrent or Metastatic Head and Neck Carcinoma (CheckMate 141)

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Bristol-Myers Squibb 361
Testing effectiveness (Phase 2)Ended earlyNCT01333852
What this trial is testing

Metformin Plus Paclitaxel for Metastatic or Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck NeoplasmsSquamous Cell Carcinoma
Lucas Vieira dos Santos 45
Testing effectiveness (Phase 2)Looking for participantsNCT07136545
What this trial is testing

A Phase I/II Trial of HCB101 in Combination With Pembrolizumab for Patients With Platinum-Refractory, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (SirH&N Trial)

Who this might be right for
HNSCC
Taipei Veterans General Hospital, Taiwan 50
Large-scale testing (Phase 3)Study completedNCT03257267
What this trial is testing

Study of Cemiplimab in Adults With Cervical Cancer

Who this might be right for
Squamous Cell Carcinoma (SCC)Recurrent or Metastatic, Platinum-refractory Cervical Cancer
Regeneron Pharmaceuticals 608